These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 3994029)
61. Validation of an automated blood culture system for sterility testing of cell therapy products. Hocquet D; Sauget M; Roussel S; Malugani C; Pouthier F; Morel P; Gbaguidi-Haore H; Bertrand X; Grenouillet F Cytotherapy; 2014 May; 16(5):692-8. PubMed ID: 24210785 [TBL] [Abstract][Full Text] [Related]
62. Calling it 'multidose' doesn't make it so: inappropriate sharing and contamination of parenteral medication vials. Schaefer MK; Shehab N; Perz JF Am J Infect Control; 2010 Sep; 38(7):580-1. PubMed ID: 20736116 [No Abstract] [Full Text] [Related]
63. The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial. Schaltz-Buchholzer F; Frankel HN; Benn CS Glob Health Action; 2017; 10(1):1-4. PubMed ID: 28169606 [TBL] [Abstract][Full Text] [Related]
64. A method for demonstrating appropriate environmental protection for capping aseptically filled and plugged vials. Arnold JF; Price JM PDA J Pharm Sci Technol; 2003; 57(6):425-8. PubMed ID: 14765558 [TBL] [Abstract][Full Text] [Related]
65. The effects of withdrawal and duration of storage on the sterility of multiple dose vials. Yang ST; Wilken LO J Parenter Sci Technol; 1987; 41(3):105-9. PubMed ID: 3612411 [No Abstract] [Full Text] [Related]
67. Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance. Woo SJ; Han JM; Ahn J; Heo JW; Yu HG; Chung H; Song J; Park KU; Park KH Retina; 2012 Apr; 32(4):667-71. PubMed ID: 22307220 [TBL] [Abstract][Full Text] [Related]
68. The cost and safety of multidose use of palivizumab vials. Gooding J; Millage A; Rye AK; Lacroix R Clin Pediatr (Phila); 2008 Mar; 47(2):160-3. PubMed ID: 17901213 [TBL] [Abstract][Full Text] [Related]
69. Assessment of infection control practices for interventional techniques: a best evidence synthesis of safe injection practices and use of single-dose medication vials. Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Helm Ii S; Wargo BW; Hansen H; Parr AT; Singh V; Hirsch JA Pain Physician; 2012; 15(5):E573-614. PubMed ID: 22996856 [TBL] [Abstract][Full Text] [Related]
70. Bacterial Contamination of Multi-dose Eye Drops at Ophthalmology Department, University of Gondar, Northwest Ethiopia. Tsegaw A; Tsegaw A; Abula T; Assefa Y Middle East Afr J Ophthalmol; 2017; 24(2):81-86. PubMed ID: 28936051 [TBL] [Abstract][Full Text] [Related]
71. Is insulin diluted when stored in water? Plager P; Nurie K; Omann T; Moran A; Piloya T; Bahendeka S; Sunni M Pediatr Diabetes; 2017 May; 18(3):237-240. PubMed ID: 26826013 [TBL] [Abstract][Full Text] [Related]
72. Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Mason HJ; Morton J; Garfitt SJ; Iqbal S; Jones K Ann Occup Hyg; 2003 Nov; 47(8):681-5. PubMed ID: 14602675 [TBL] [Abstract][Full Text] [Related]
73. Sterility validity period of vials after multiple sampling under vertical laminar airflow hood. De Giorgi I; Sadeghipour F; Favet J; Bonnabry P J Oncol Pharm Pract; 2005 Jun; 11(2):57-62. PubMed ID: 16460606 [TBL] [Abstract][Full Text] [Related]
74. Iatrogenic contamination of multidose vials in simulated use. A reassessment of current patient injection technique. Plott RT; Wagner RF; Tyring SK Arch Dermatol; 1990 Nov; 126(11):1441-4. PubMed ID: 2173497 [TBL] [Abstract][Full Text] [Related]
75. Use and sterility of multidose ophthalmic medications. Tamer HR; Sweet BV; Ross MB Am J Hosp Pharm; 1994 Feb; 51(4):500-2. PubMed ID: 8017416 [TBL] [Abstract][Full Text] [Related]
77. Anterior chamber contamination after uncomplicated phacoemulsification and intraocular lens implantation. Samad A; Solomon LD; Miller MA; Mendelson J Am J Ophthalmol; 1995 Aug; 120(2):143-50. PubMed ID: 7639297 [TBL] [Abstract][Full Text] [Related]
78. The Thai Anesthesia Incidents Study (THAI study) of ambulatory anesthesia: II. Anesthetic profiles and adverse events. Punjasawadwong Y; Srisawasdi S; Werawatganon T; Taratarnkoolwatana K; Chau-in W; Vasinanukorn M J Med Assoc Thai; 2008 Feb; 91(2):188-95. PubMed ID: 18389983 [TBL] [Abstract][Full Text] [Related]
79. Verification of surface contamination of Japanese cyclophosphamide vials and an example of exposure by handling. Hama K; Fukushima K; Hirabatake M; Hashida T; Kataoka K J Oncol Pharm Pract; 2012 Jun; 18(2):201-6. PubMed ID: 21947739 [TBL] [Abstract][Full Text] [Related]
80. Quantifying the Vial Capping Process: Residual Seal Force and Container Closure Integrity. Ovadia R; Streubel A; Webb-Vargas Y; Ulland L; Luemkemann J; Rauch K; Eder J; Lam P; Tegoulia V; Maa YF PDA J Pharm Sci Technol; 2019; 73(1):2-15. PubMed ID: 29954924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]